Antibacterial Photodynamic Therapy by Zn(II)‐Curcumin Complex: Synthesis, Characterization, DFT Calculation, Antibacterial Activity, and Molecular Docking

Abstract

AbstractThe increase in antibacterial drug resistance is threatening global health conditions. Recently, antibacterial photodynamic therapy (aPDT) has emerged as an effective antibacterial treatment with high cure gain. In this work, three Zn(II) complexes viz., [Zn(en)(acac)Cl] (1), [Zn(bpy)(acac)Cl] (2), [Zn(en)(cur)Cl] (3), where en=ethylenediamine (1 and 3), bpy=2,2’‐bipyridine (2), acac=acetylacetonate (1 and 2), cur=curcumin monoanionic (3) were developed as aPDT agents. Complexes 1–3 were synthesized and fully characterized using NMR, HRMS, FTIR, UV‐Vis. and fluorescence spectroscopy. The HOMO–LUMO energy gap (Eg), and adiabatic splittings (ΔS1−T1 and ΔS0−T1) obtained from DFT calculation indicated the photosensivity of the complexes. These complexes have not shown any potent antibacterial activity under dark conditions but the antibacterial activity of these complexes was significantly enhanced upon light exposure (MIC value up to 0.025 μg/mL) due to their light‐mediated 1O2 generation abilities. The molecular docking study suggested that complexes 1–3 interact efficiently with DNA gyrase B (PDB ID: 4uro). Importantly, 1–3 did not show any toxicity toward normal HEK‐293 cells. Overall, in this work, we have demonstrated the promising potential of Zn(II) complexes as effective antibacterial agents under the influence of visible light.